サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1541157

神経リハビリテーション機器市場レポート：製品タイプ、用途、エンドユーザー、地域別、2024年～2032年

Neurorehabilitation Devices Market Report by Product Type, Application, End User, and Region 2024-2032

出版日
発行
IMARC
ページ情報
英文 141 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
神経リハビリテーション機器市場レポート：製品タイプ、用途、エンドユーザー、地域別、2024年～2032年
出版日: 2024年08月10日
発行: IMARC
ページ情報: 英文 141 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の神経リハビリテーション機器市場規模は2023年に19億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに43億米ドルに達し、2024年から2032年の間に9.5％の成長率（CAGR）を示すと予測しています。

神経リハビリ機器とは、脳や中枢神経系（CNS）の検査に使用される機器を指します。一般的に使用されている機器には、神経ロボットシステム、非侵襲的脳刺激装置、神経人工器官、ブレイン・コンピュータ・インターフェイス、ウェアラブル機器などがあります。これらの機器は、患者の神経系における疾患、障害、傷害の診断と治療を支援します。また、パーキンソン病や心血管系脳卒中などの神経疾患から、運動技能の再学習や最適な回復を促進します。その結果、ニューロリハビリテーション機器は、様々なクリニック、認知ケア、研究機関、ヘルスケアセンターで幅広く使用されています。

神経リハビリテーション機器市場動向：

多発性硬化症、パーキンソン病、脳性麻痺などの神経疾患の有病率の増加は、市場成長を促進する主な要因の1つです。さらに、このような病気にかかりやすい老年人口の増加が、市場の成長を後押ししています。神経リハビリ機器は、手足の動きを回復させるために、脊髄の複数の繊維に多様な電気信号を展開するのに役立ちます。さらに、仮想現実（VR）やロボット工学、人工知能（AI）によるリハビリ活動のゲーミフィケーションなど、回復を促進するさまざまな技術的進歩が、その他の成長促進要因として作用しています。これに伴い、脊髄損傷の治療に新しい多電極刺激を利用することも市場成長に寄与しています。その他の要因としては、大衆の医療支出能力の上昇、広範な研究開発（R&D）活動などがあり、市場をさらに牽引すると予想されます。

本レポートで扱う主な質問

  • 2023年の世界の神経リハビリテーション機器市場の市場規模は？
  • 2024年から2032年にかけての世界の神経リハビリテーション機器市場の予想成長率は？
  • 世界の神経リハビリテーション機器市場を牽引する主要因は何か？
  • 世界の神経リハビリテーション機器市場に対するCOVID-19の影響は？
  • 世界の神経リハビリテーション機器市場の製品タイプ別内訳は？
  • 世界の神経リハビリテーション機器市場の用途別内訳は？
  • 世界の神経リハビリテーション機器市場のエンドユーザー別内訳は？
  • 神経リハビリテーション機器市場の世界における主要地域は？
  • 世界の神経リハビリテーション機器市場における主要プレイヤー/企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の神経リハビリテーション機器市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品タイプ別

  • 神経ロボットデバイス
    • 市場動向
    • 市場予測
  • ウェアラブルデバイス
    • 市場動向
    • 市場予測
  • 非侵襲性刺激装置
    • 市場動向
    • 市場予測
  • 脳コンピュータインターフェース
    • 市場動向
    • 市場予測

第7章 市場内訳：用途別

  • 脳卒中
    • 市場動向
    • 市場予測
  • 多発性硬化症
    • 市場動向
    • 市場予測
  • パーキンソン病
    • 市場動向
    • 市場予測
  • 脳性麻痺
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳：エンドユーザー別

  • 病院と診療所
    • 市場動向
    • 市場予測
  • 認知ケアセンター
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Biometrics Ltd
    • Bioness Inc.
    • Bionik Laboratories Corp
    • BioXtreme Ltd.
    • Boston Scientific Corporation
    • Ectron Ltd
    • Ekso Bionics
    • Hocoma AG（DIH International Limited）
    • Kinestica
    • Kinova Inc.
    • Medtronic plc
    • Saebo Inc
    • Tyromotion GmbH
図表

List of Figures

  • Figure 1: Global: Neurorehabilitation Devices Market: Major Drivers and Challenges
  • Figure 2: Global: Neurorehabilitation Devices Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Neurorehabilitation Devices Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Neurorehabilitation Devices Market: Breakup by Product Type (in %), 2023
  • Figure 5: Global: Neurorehabilitation Devices Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Neurorehabilitation Devices Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Neurorehabilitation Devices Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Neurorehabilitation Devices (Neurorobotic Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Neurorehabilitation Devices (Neurorobotic Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Neurorehabilitation Devices (Wearable Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Neurorehabilitation Devices (Wearable Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Neurorehabilitation Devices (Non-Invasive Stimulators) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Neurorehabilitation Devices (Non-Invasive Stimulators) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Neurorehabilitation Devices (Brain-Computer Interface) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Neurorehabilitation Devices (Brain-Computer Interface) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Neurorehabilitation Devices (Stroke) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Neurorehabilitation Devices (Stroke) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Neurorehabilitation Devices (Multiple Sclerosis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Neurorehabilitation Devices (Multiple Sclerosis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Neurorehabilitation Devices (Parkinson's Disease) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Neurorehabilitation Devices (Parkinson's Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Neurorehabilitation Devices (Cerebral Palsy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Neurorehabilitation Devices (Cerebral Palsy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Neurorehabilitation Devices (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Neurorehabilitation Devices (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Neurorehabilitation Devices (Hospitals and Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Neurorehabilitation Devices (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Neurorehabilitation Devices (Cognitive Care Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Neurorehabilitation Devices (Cognitive Care Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Neurorehabilitation Devices (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Neurorehabilitation Devices (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: North America: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: North America: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: United States: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: United States: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Canada: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Canada: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Asia-Pacific: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Asia-Pacific: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: China: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: China: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Japan: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Japan: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: India: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: India: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: South Korea: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: South Korea: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Australia: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Australia: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Indonesia: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Indonesia: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Others: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Others: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Europe: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Europe: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Germany: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Germany: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: France: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: France: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: United Kingdom: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: United Kingdom: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Italy: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Italy: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Spain: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Spain: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Russia: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Russia: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Others: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Others: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Latin America: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Latin America: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Brazil: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Brazil: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Mexico: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Mexico: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Others: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Others: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Middle East and Africa: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Middle East and Africa: Neurorehabilitation Devices Market: Breakup by Country (in %), 2023
  • Figure 80: Middle East and Africa: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Global: Neurorehabilitation Devices Industry: SWOT Analysis
  • Figure 82: Global: Neurorehabilitation Devices Industry: Value Chain Analysis
  • Figure 83: Global: Neurorehabilitation Devices Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Neurorehabilitation Devices Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Neurorehabilitation Devices Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
  • Table 3: Global: Neurorehabilitation Devices Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Neurorehabilitation Devices Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: Neurorehabilitation Devices Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Neurorehabilitation Devices Market: Competitive Structure
  • Table 7: Global: Neurorehabilitation Devices Market: Key Players
目次
Product Code: SR112024A4005

The global neurorehabilitation devices market size reached US$ 1.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.3 Billion by 2032, exhibiting a growth rate (CAGR) of 9.5% during 2024-2032.

Neurorehabilitation devices refer to the equipment used for examination of the brain and central nervous system (CNS). Some of the commonly used devices include neurorobotic systems, non-invasive brain stimulators, neuroprosthetics, brain-computer interfaces and wearable devices. These devices assist in the diagnosis and treatment of a disease, disorder or injury in the nervous system of the patient. They facilitate in re-learning motor skills and optimal recovery from neurological disorders, such as Parkinson's disease, and cardiovascular stroke. As a result, neurorehabilitation devices find extensive applications across various clinics, cognitive care and research institutes and healthcare centers.

Neurorehabilitation Devices Market Trends:

The increasing prevalence of neurological diseases, such as multiple sclerosis, Parkinson's disease and cerebral palsy, is one of the key factors driving the market growth. Moreover, the rising geriatric population, which is more susceptible to such ailments, is providing a thrust to the growth of the market. Neurorehabilitation devices aid in deploying diversified electric signals to multiple fibers of the spinal cord for the recovery of limb movements. Additionally, various technological advancements, such as the gamification of rehabilitation activities through virtual reality (VR), robotics and artificial intelligence (AI), that aid in promoting recovery are acting as other growth-inducing factors. In line with this, the utilization of novel multi-electrode stimulation for the treatment of spinal cord injuries is also contributing to the market growth. Other factors, including rising healthcare expenditure capacities of the masses, along with extensive research and development (R&D) activities, are anticipated to drive the market further.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global neurorehabilitation devices market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product type, application and end user.

Breakup by Product Type:

Neurorobotic Devices

Wearable Devices

Non-Invasive Stimulators

Brain-Computer Interface

Breakup by Application:

Stroke

Multiple Sclerosis

Parkinson's Disease

Cerebral Palsy

Others

Breakup by End User:

Hospitals and Clinics

Cognitive Care Centers

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Biometrics Ltd, Bioness Inc., Bionik Laboratories Corp, BioXtreme Ltd., Boston Scientific Corporation, Ectron Ltd, Ekso Bionics, Hocoma AG (DIH International Limited), Kinestica, Kinova Inc., Medtronic plc, Saebo Inc and Tyromotion GmbH.

Key Questions Answered in This Report

  • 1. What was the size of the global neurorehabilitation devices market in 2023?
  • 2. What is the expected growth rate of the global neurorehabilitation devices market during 2024-2032?
  • 3. What are the key factors driving the global neurorehabilitation devices market?
  • 4. What has been the impact of COVID-19 on the global neurorehabilitation devices market?
  • 5. What is the breakup of the global neurorehabilitation devices market based on the product type?
  • 6. What is the breakup of the global neurorehabilitation devices market based on the application?
  • 7. What is the breakup of the global neurorehabilitation devices market based on the end user?
  • 8. What are the key regions in the global neurorehabilitation devices market?
  • 9. Who are the key players/companies in the global neurorehabilitation devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Neurorehabilitation Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Neurorobotic Devices
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Wearable Devices
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Non-Invasive Stimulators
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Brain-Computer Interface
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Stroke
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Multiple Sclerosis
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Parkinson's Disease
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Cerebral Palsy
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals and Clinics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Cognitive Care Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Biometrics Ltd
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Bioness Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Bionik Laboratories Corp
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
    • 14.3.4 BioXtreme Ltd.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Boston Scientific Corporation
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Ectron Ltd
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Ekso Bionics
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Hocoma AG (DIH International Limited)
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Kinestica
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Kinova Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Medtronic plc
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Saebo Inc
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
    • 14.3.13 Tyromotion GmbH
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 Financials